Thomas Watkins - 28 Apr 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Apr 2022
Net transactions value
$0
Form type
4
Filing time
02 May 2022, 18:15:34 UTC
Previous filing
14 Jun 2021
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +4,223 +6% 75,164 29 Apr 2022 By Trust F1
holding HZNP Ordinary Shares 6,000 28 Apr 2022 Direct
holding HZNP Ordinary Shares 10,000 28 Apr 2022 By Family Limited Partnership

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Award $0 +3,913 $0.000000 3,913 28 Apr 2022 Ordinary shares 3,913 Direct F1
transaction HZNP Restricted Stock Units Options Exercise $0 -4,223 -100% $0.000000* 0 29 Apr 2022 Ordinary shares 4,223 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.